Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst

Japan |  Analysis | By BioSpectrum Bureau | 0 Comment | 21 Aug, 2015

Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021, representing a moderate compound annual growth rate (CAGR) of 4.6 pe...Read more

Teijin, Pulmagen enter agreement for asthma drug

Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Sep, 2012

Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeutics, a UK-based drug development company, have signed an exclusive l...Read more

Australian Cellmid acquires Japanese Advangen

Japan |  News | By BioSpectrum Bureau | 0 Comment | 09 May, 2013

Singapore: Australia-based Cellmid plans to acquire Japanese firm Advangen that owns the FGF-5 inhibitor hair growth technology. Cellmid markets évolis hair product range, which was orig...Read more

Belgium 3D printing firm forays into Japan

Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

Materialise NV, a Belgium-based provider of 3D software and sophisticated 3D printing solutions, and a pioneer in medical image-based guided technology, has signed a 5-year partnership agre...Read more

Japan's Mitsubishi Tanabe pharma to revamp operations

Japan |  News | By BioSpectrum Bureau | 0 Comment | 28 Jul, 2015

Singapore: With a view to streamline operations and speed up new drug launches, Japan's Mitsubishi Tanabe pharma recently announced plans to revamp and reorganize its three drug development...Read more

NTT's conductive fiber to help in biomedical recordings

Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013

Singapore: Japanese company Nippon Telegraph and Telephone Corporation (NTT) has developed a conductive fiber by coating the surface of silk or synthetic fiber with conductive polymer (PEDO...Read more

Daiichi, ArQule enroll patient for cancer trial

Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Feb, 2013

Singapore: Daiichi Sankyo and ArQule announced that the first patient has been enrolled in the pivotal phase III METIV-HCC (MET-high patients with tivantinib in HCC) trial of tivantinib (A...Read more

Three major Japanese labs collaborate on Parkinson's disease research

Japan |  News | By BioSpectrum Bureau | 0 Comment | 27 Jul, 2015

Tokyo: Sumitomo Dainippon Pharma Co. Ltd., Center for iPS Cell Research and Application, Kyoto University (CiRA) and Hitachi Ltd. have signed a collaborative research program based on induc...Read more

BIO joins coalition to caution against further restructuring of Japan's Pharmaceutical Pricing

Japan |  News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015

Biotechnology Industry Organization (BIO) has made an announcement that the organization has joined a coalition of organizations urging the Government of Japan to maintain the established r...Read more

Japanese researchers discover potential drug target for muscle disease

Japan |  News | By BioSpectrum Bureau | 0 Comment | 24 Aug, 2015

Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers have designed a model that reprograms fibroblasts to the early stage...Read more

Biocon, Fujifilm launch Insulin Glargine in Japan

Japan |  News | By BioSpectrum Bureau | 0 Comment | 19 Jul, 2016

Singapore: Marking a major achievement in Indian biosimilar history, India's Biocon announced that close on the heels of receiving approval for its IQsulin Glargine from the Japanese regula...Read more

Takeda USA joins National Pharmaceutical Council

Japan |  News | By BioSpectrum Bureau | 0 Comment | 15 Jul, 2015

Tokyo: The National Pharmaceutical Council (NPC) has inducted Takeda Pharmaceuticals USA Inc. (Takeda), a wholly-owned subsidiary of Japanese pharmaceutical major Takeda Pharmaceutical Comp...Read more

No more needles, no more pain!

Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015

Singapore: Vaccination will no longer be a painful process as researchers from Japan's Osaka University have developed a new technique that can deliver vaccines without needles. The new met...Read more

HUYA appoints Yoshiki Shimamura as VP for Japan Operations

Japan |  News | By BioSpectrum Bureau | 0 Comment | 01 Jul, 2015

The international operation of Chinese pharmaceutical company, HUYA Bioscience International (HUYA) has expanded its Senior Management Team, with the appointment of Yoshiki Shimamura as Vic...Read more

Kowa, Chugai to market liver cancer drug

Japan |  News | By BioSpectrum Bureau | 0 Comment | 21 Jul, 2015

Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug peretinoin under which Kowa will acquire the marketing authorization, and...Read more

Daiichi Sankyo to develop Cell Therapy's Heartcel for Japanese market

Japan |  News | By BioSpectrum Bureau | 0 Comment | 11 May, 2016

Daiichi Sankyo Company Limited has signed a license agreement with UK-based Cell Therapy Ltd for an exclusive license in Japan to develop and market Heartcel, a immune-modulatory progenitor...Read more

RaQualia, Interprotein to research on pain drug

Japan |  News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2013

Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus on drug discovery research for a specific protein-protein interactio...Read more

Japan accepts Pluristem's regenerative cells as safe

Japan |  News | By BioSpectrum Bureau | 0 Comment | 13 Aug, 2015

Israel's Pluristem Therapeutics Inc. has announced that Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has cleared the company's PLX-PAD cells for use in clinical trials in Japan...Read more